Outlook Therapeutics Inc.
OTLK | NASDAQ
$0.70
+$0.01 (+2.00%)
Sep 22, 2026, 12:51 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 29, 2025 | FY 2024 Sep 29, 2024 | FY 2023 Sep 29, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.41M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 756.33K | 113.86K | 44.19K | 204.69K | 262.14K | 554.07K |
Gross Profit | 657.21K | -113.86K | -44.19K | -204.69K | -262.14K | -554.07K |
Operating Income | -67.06M | -71.7M | -53.13M | -63.07M | -51.73M | -36.84M |
Interest Income | 89.74K | 906.15K | n/a | n/a | n/a | n/a |
Pretax Income | -63.98M | -75.36M | -58.98M | -66.05M | -53.16M | -38.51M |
Net Income | -62.42M | -75.37M | -58.98M | -66.05M | -53.16M | -35.24M |
Selling & General & Admin | 39.94M | 29.94M | 26.67M | 20.74M | 12.77M | 9.97M |
Research & Development | 27.18T | 41.76M | 26.45M | 42.33M | 38.96M | 26.34M |
Other Expenses | -27.18T | n/a | n/a | -205K | n/a | -1.9M |
Operating Expenses | 67.72M | 71.7M | 53.13M | 62.87M | 51.73M | 34.42M |
Interest Expense | 283.13K | 3.16M | 1.56M | 1.49M | 936.13K | 1.76M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 68.48M | 71.7M | 53.13M | 63.07M | 51.73M | 36.84M |
Income Tax Expense | -1.55M | 2.8K | 2.8K | 2.8K | 2K | -3.27M |
Shares Outstanding (Basic) | 34.8M | 18.55M | 12.51M | 10.6M | 7.63M | 3.63M |
Shares Outstanding (Diluted) | 25.48M | 18.55M | 12.51M | 10.6M | 7.63M | 3.63M |
EPS (Basic) | -1.79 | -4.06 | -4.72 | -6.23 | -6.96 | -13.47 |
EPS (Diluted) | -1.79 | -4.06 | -4.72 | -6.23 | -6.96 | -13.47 |
EBITDA | -63.58M | -72.09M | -57.38M | -64.36M | -51.51M | -36.2M |
EBIT | -63.69M | -72.21M | -57.42M | -64.56M | -51.73M | -36.76M |
Depreciation & Amortization | 117.05K | 113.86K | 44.19K | 204.69K | 262.14K | 554.07K |
Add to Watchlist
Select watchlists to add or remove OTLK